Doris J Bucher

Title: Doris J Bucher: Innovator in Antiviral Research

Introduction

Doris J Bucher is a prominent inventor based in New York, NY (US), known for her significant contributions to antiviral research. With a total of 5 patents, she has made remarkable strides in the field of influenza virus treatment and prevention.

Latest Patents

Among her latest patents, one notable invention is related to M-protein peptides of the influenza virus as antiviral agents. These peptides, which correspond to the 148-162 region of type A influenza M protein, have been shown to possess high activity as influenza transcription inhibitors. This makes them valuable as antiviral agents against influenza virus and other RNA viruses. Additionally, she has developed methods for modifying these peptides by incorporating them into liposomes or adding long-chain alkylamino acids, enhancing their effectiveness in antiviral drug formulations. Another significant patent involves macromolecular conjugates of a synthetic polypeptide that exhibit influenza virus antigenic properties. These conjugates contain a polypeptide corresponding to the 215-235 region of the matrix protein (M-protein) of the influenza virus.

Career Highlights

Doris has worked with esteemed organizations such as SRI International and Mount Sinai School of Medicine. Her work in these institutions has allowed her to advance her research and contribute to the scientific community significantly.

Collaborations

Throughout her career, Doris has collaborated with notable individuals, including Amrit K Judd and Steven W Popple. These collaborations have further enriched her research and innovation in the field.

Conclusion

Doris J Bucher stands out as an influential inventor in antiviral research, with her innovative patents paving the way for advancements in influenza treatment. Her contributions continue to impact the scientific community and public health positively.